tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Psychedelic: Compass Pathways achieves primary endpoint in COMP360 trial
PremiumThe FlyPsychedelic: Compass Pathways achieves primary endpoint in COMP360 trial
2M ago
Enveric announces data broadening clinical potential for lead candidate
Premium
The Fly
Enveric announces data broadening clinical potential for lead candidate
2M ago
Psychedelic: Clearmind engages government, political affairs consulting firm
Premium
The Fly
Psychedelic: Clearmind engages government, political affairs consulting firm
2M ago
Enveric Biosciences announces results from EB-003 trial
PremiumThe FlyEnveric Biosciences announces results from EB-003 trial
3M ago
Psychedelic: atai Life Sciences reports Phase 2a study data on BPL-003
Premium
The Fly
Psychedelic: atai Life Sciences reports Phase 2a study data on BPL-003
3M ago
Enveric Biosciences files new provisional patent application
Premium
The Fly
Enveric Biosciences files new provisional patent application
3M ago
Enveric Biosciences launches RFP solicitation process for PsyAI trademark
PremiumThe FlyEnveric Biosciences launches RFP solicitation process for PsyAI trademark
6M ago
Promising Developments and Patent Milestone Bolster Buy Rating for Enveric Biosciences
Premium
Ratings
Promising Developments and Patent Milestone Bolster Buy Rating for Enveric Biosciences
6M ago
Psychedelic: GH Research, Compass Pathways report earnings results
Premium
The Fly
Psychedelic: GH Research, Compass Pathways report earnings results
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100